Dalriada Drug Discovery and Topos Bio Announce Collaboration to Advance Drug Discovery for Intrinsically Disordered Proteins
Toronto, ON and San Francisco, CA — March 17, 2026 — Dalriada Drug Discovery (“Dalriada”), a partnered discovery organization supporting small-molecule programs from hit identification through lead optimization, and Topos